Effectiveness of Bulb Extracts of the Genus Allium

Total Page:16

File Type:pdf, Size:1020Kb

Effectiveness of Bulb Extracts of the Genus Allium Effectiveness of Bulb Extracts of the Genus Allium Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) dem Fachbereich Pharmazie der Philipps-Universität Marburg vorgelegt von M.Sc. Sahar Samadi aus Tehran, Iran Marburg/Lahn 2018 Erstgutachter: Prof. Dr. Michael Keusgen Zweitgutachter: Prof. Dr. Klaus Reuter Eingereicht am 24 May 2018 Tag der mündlichen Prüfung am 11 July 2018 Hochschulkennziffer 1180 III Preface This thesis is the result of a research project that I carried out at the institute of pharmacy at Philipps-Universität Marburg. During this research I received academic and practical supports from different persons whom I would like to acknowledge here. First of all, I would like to express my sincere gratitude to my advisor Prof. Dr. Michael Keusgen for his continuous support, patience, motivation, and immense knowledge. His guidance helped me in all the time of research and writing of this thesis. Next, I would like to thank my thesis committee: Prof. Dr. Maike Petersen, Prof. Dr. Moritz Bünemannand and Prof. Dr. Klaus Reuter for taking the time to review this work and also for their insightful comments. I would like also to thank my colleagues and fellow lab mates for the stimulating discussions, for working together before deadlines, and for all the funs we had together. I wish also to acknowledge the role of my parents and my sister for their spiritual supports and their blessings throughout this research. Finally, I would like to acknowledge the most important person in my life – my husband Meysam, who has been a constant source of strength and inspiration. I can honestly say that it was only his determination and constant encouragement that ultimately made it possible for me to see this project through to the end. IV Table of Contents Preface ......................................................................................................................... III List of abbreviation .................................................................................................... VII Abstract .................................................................................................................... VIII 1. .................................................................................................................. Introduction ........................................................................................................................................ 1 1.1 History of natural products as medicines ........................................................... 1 1.1.1 Natural products from plant sources.............................................................................. 2 1.1.2 Plant products as antimicrobial agents .......................................................................... 2 1.2 The Genus Allium ................................................................................................ 4 1.2.1 The genus Allium and its phylogenetic classification ..................................................... 4 1.2.2 Pharmaceutical relevance of the genus Allium............................................................... 5 1.2.3 Alliinase reaction ......................................................................................................... 8 1.3 Fungi as plant pathogenic ................................................................................. 12 1.3.1 Aspergillus flavus ....................................................................................................... 12 1.3.2 Aspergillus niger ........................................................................................................ 14 1.3.3 Mucor hiemalis .......................................................................................................... 15 1.3.4 Penicillium italicum ................................................................................................... 16 1.4 Fungi as Human Pathogens (Dermatophyte) ................................................... 17 1.4.1 Basidiobolus ranarum ................................................................................................ 17 1.4.2 Cryptococcus neoformans .......................................................................................... 18 1.4.3 Epidermophyton floccosum......................................................................................... 19 1.5 Bioassays ............................................................................................................ 20 1.6 Antimicrobial susceptibility testing .................................................................. 20 2. ...................................................................................................... Aims and objectives ...................................................................................................................................... 22 2.1 Objectives .......................................................................................................... 22 V 3. ................................................................................................. Materials and Methods ...................................................................................................................................... 23 3.1 List of reagents and instruments ...................................................................... 23 3.2 Plant material ................................................................................................... 24 3.2.1 List of Allium samples ................................................................................................ 25 3.3 Microorganisms ................................................................................................ 27 3.3.1 Inoculum preparation ................................................................................................. 27 3.4 Plant Processing ................................................................................................ 28 3.4.1 Plant processing for bioactivity tests ........................................................................... 28 3.4.2 Plant Processing for Analysis of Volatile Sulfur Compounds ...................................... 28 3.5 Bioassay methods .............................................................................................. 28 3.5.1 Broth microdilution method ....................................................................................... 28 3.5.2 Agar microdilution method ........................................................................................ 30 3.5.3 Disk diffusion method ................................................................................................ 32 3.5.4 Double-dish chamber ................................................................................................. 33 3.5.5 Antimicrobial assay of different fractions ................................................................... 34 3.6 Instrumental Setup for bioactivity tests ........................................................... 34 3.6.1 HPLC Separation of the Volatile Sulfur Compounds .................................................. 34 3.6.2 HPLC micro-fractionation .......................................................................................... 35 3.6.3 HPLC-MS Analysis of the effective fractions ............................................................. 35 3.6.4 Structure Elucidation .................................................................................................. 35 4. ........................................................................................................................... Results ...................................................................................................................................... 36 4.1 Selection and development of methods ............................................................ 36 4.2 Results regarding plant pathogenic fungi ........................................................ 36 4.2.1 Broth microdilution method ....................................................................................... 37 4.2.2 Agar microdilution method ........................................................................................ 37 4.2.3 Disk diffusion test ...................................................................................................... 45 4.2.4 Double-dish chamber ................................................................................................. 50 4.3 Results regarding human pathogenic fungi ..................................................... 52 4.3.1 Agar microdilution method ........................................................................................ 52 4.3.2 Disk diffusion test ...................................................................................................... 56 4.3.3 Double-dish chamber ................................................................................................. 59 4.3.4 Summarized results regarding human pathogenic fungi .............................................. 60 4.4 Allium stipitatum, Identification of active substances ...................................... 61 VI 4.5 Bioassay-guided fractionation and isolation of the active compounds (Prep HPLC). ......................................................................................................................... 62 4.6 LC-MS adducts general Interpretation of A. stipitatum................................... 63 4.7 Chemical
Recommended publications
  • Biological and Landscape Diversity in Slovenia
    MINISTRY OF THE ENVIRONMENT AND SPATIAL PLANNING ENVIRONMENTAL AGENCY OF THE REPUBLIC OF SLOVENIA Biological and Landscape Diversity in Slovenia An overview CBD Ljubljana, 2001 MINISTRY OF THE ENVIRONMENTAL AND SPATIAL PLANNING ENVIRONMENTAL AGENCY OF THE REPUBLIC OF SLOVENIA Published by: Ministry of the Environment and Spatial Planning - Environmental Agency of the Republic of Slovenia Editors in chief and executive editors: Branka Hlad and Peter Skoberne Technical editor: Darja Jeglič Reviewers of the draft text: Kazimir Tarman Ph.D., Andrej Martinčič Ph.D., Fedor Černe Ph.D. English translation: Andreja Naraks Gordana Beltram Ph.D. (chapter on Invasive Species, ......., comments on the figures), Andrej Golob (chapter on Communication, Education and Public Awareness) Revision of the English text: Alan McConnell-Duff Ian Mitchell (chapter on Communication, Education and Public Awareness) Gordana Beltram Ph.D. Designed and printed by: Littera Picta d.o.o. Photographs were contributed by: Milan Orožen Adamič (2), Matjaž Bedjanič (12), Gordana Beltram (3), Andrej Bibič (2), Janez Božič (1), Robert Bolješič (1), Branka Hlad (15), Andrej Hudoklin (10), Hojka Kraigher (1), Valika Kuštor (1), Bojan Marčeta (1), Ciril Mlinar (3), Marko Simić (91), Peter Skoberne (57), Baldomir Svetličič (1), Martin Šolar (1), Dorotea Verša (1) and Jana Vidic (2). Edition: 700 copies CIP - Kataložni zapis o publikaciji Narodna in univerzitetna knjižnica, Ljubljana 502.3(497.4)(082) 574(497.4)(082) BIOLOGICAL and landscape diversity in Slovenia : an overview / (editors in chief Branka Hlad and Peter Skoberne ; English translation Andreja Naraks, Gordana Beltram, Andrej Golob; photographs were contributed by Milan Orožen Adamič... et. al.). - Ljubljana : Ministry of the Environment and Spatial Planning, Environmental Agency of the Republic of Slovenia, 2001 ISBN 961-6324-17-9 I.
    [Show full text]
  • NEWSLETTER 2017•Issue 2
    NEWSLETTER 2017•Issue 2 page 2 Deep dermatophytosis page 4 Deep dermatophytosis: A case report page 5 Fereydounia khargensis: A new and uncommon opportunistic yeast from Malaysia page 6 Itraconazole: A quick guide for clinicians Visit us at AFWGonline.com and sign up for updates Editors’ welcome Dr Mitzi M Chua Dr Ariya Chindamporn Adult Infectious Disease Specialist Associate Professor Associate Professor Department of Microbiology Department of Microbiology & Parasitology Faculty of Medicine Cebu Institute of Medicine Chulalongkorn University Cebu City, Philippines Bangkok, Thailand This year we celebrate the 8th year of AFWG: 8 years of pursuing excellence in medical mycology throughout the region; 8 years of sharing expertise and encouraging like-minded professionals to join us in our mission. We are happy to once again share some educational articles from our experts and keep you updated on our activities through this issue. Deep dermatophytosis may be a rare skin infection, but late diagnosis or ineffective treatment may lead to mortality in some cases. This issue of the AFWG newsletter focuses on this fungal infection that usually occurs in immunosuppressed individuals. Dr Pei-Lun Sun takes us through the basics of deep dermatophytosis, presenting data from published studies, and emphasizes the importance of treating superficial tinea infections before starting immunosuppressive treatment. Dr Ruojun Wang and Professor Ruoyu Li share a case of deep dermatophytosis caused by Trichophyton rubrum. In this issue, we also feature a new fungus, Fereydounia khargensis, first discovered in 2014. Ms Ratna Mohd Tap and Dr Fairuz Amran present 2 cases of F. khargensis and show how PCR sequencing is crucial to correct identification of this uncommon yeast.
    [Show full text]
  • Introduction to Mycology
    INTRODUCTION TO MYCOLOGY The term "mycology" is derived from Greek word "mykes" meaning mushroom. Therefore mycology is the study of fungi. The ability of fungi to invade plant and animal tissue was observed in early 19th century but the first documented animal infection by any fungus was made by Bassi, who in 1835 studied the muscardine disease of silkworm and proved the that the infection was caused by a fungus Beauveria bassiana. In 1910 Raymond Sabouraud published his book Les Teignes, which was a comprehensive study of dermatophytic fungi. He is also regarded as father of medical mycology. Importance of fungi: Fungi inhabit almost every niche in the environment and humans are exposed to these organisms in various fields of life. Beneficial Effects of Fungi: 1. Decomposition - nutrient and carbon recycling. 2. Biosynthetic factories. The fermentation property is used for the industrial production of alcohols, fats, citric, oxalic and gluconic acids. 3. Important sources of antibiotics, such as Penicillin. 4. Model organisms for biochemical and genetic studies. Eg: Neurospora crassa 5. Saccharomyces cerviciae is extensively used in recombinant DNA technology, which includes the Hepatitis B Vaccine. 6. Some fungi are edible (mushrooms). 7. Yeasts provide nutritional supplements such as vitamins and cofactors. 8. Penicillium is used to flavour Roquefort and Camembert cheeses. 9. Ergot produced by Claviceps purpurea contains medically important alkaloids that help in inducing uterine contractions, controlling bleeding and treating migraine. 10. Fungi (Leptolegnia caudate and Aphanomyces laevis) are used to trap mosquito larvae in paddy fields and thus help in malaria control. Harmful Effects of Fungi: 1.
    [Show full text]
  • Antifungal Topical Step Therapy Policy 1380-D 06-2017 (1) ©2017 CVS Caremark
    STEP THERAPY CRITERIA DRUG CLASS TOPICAL ANTIFUNGAL AGENTS (BRAND PRODUCTS ONLY) BRAND NAME (generic) ECOZA (econazole) ERTACZO (sertaconazole) EXELDERM (sulconazole nitrate) LOPROX (ciclopirox shampoo) LOTRISONE (clotrimazole/betamethasone) LUZU (luliconazole) MENTAX (butenafine) NAFTIN (naftifine) OXISTAT (oxiconazole) VUSION (miconazole/zinc oxide/white petrolatum) XOLEGEL (ketoconazole) Status: CVS Caremark Criteria Type: Initial Step Therapy; Post Step Therapy Prior Authorization Antifungal Topical Step Therapy Policy 1380-D 06-2017 (1) ©2017 CVS Caremark. All rights reserved. This document contains confidential and proprietary information of CVS Caremark and cannot be reproduced, distributed or printed without written permission from CVS Caremark. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. 1 POLICY FDA-APPROVED INDICATIONS Ecoza Ecoza topical 1% foam is indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older. Ertaczo Ertaczo 2% cream is indicated for the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by: Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum. Exelderm Exelderm 1% cream is indicated for the treatment of tinea pedis (athlete’s foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis, and for the treatment of tinea versicolor. Exelderm 1% solution is indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; and for the treatment of tinea versicolor. Effectiveness has not been proven in tinea pedis (athlete’s foot).
    [Show full text]
  • Essential Oils of Lamiaceae Family Plants As Antifungals
    biomolecules Review Essential Oils of Lamiaceae Family Plants as Antifungals Tomasz M. Karpi ´nski Department of Medical Microbiology, Pozna´nUniversity of Medical Sciences, Wieniawskiego 3, 61-712 Pozna´n,Poland; [email protected] or [email protected]; Tel.: +48-61-854-61-38 Received: 3 December 2019; Accepted: 6 January 2020; Published: 7 January 2020 Abstract: The incidence of fungal infections has been steadily increasing in recent years. Systemic mycoses are characterized by the highest mortality. At the same time, the frequency of infections caused by drug-resistant strains and new pathogens e.g., Candida auris increases. An alternative to medicines may be essential oils, which can have a broad antimicrobial spectrum. Rich in the essential oils are plants from the Lamiaceae family. In this review are presented antifungal activities of essential oils from 72 Lamiaceae plants. More than half of these have good activity (minimum inhibitory concentrations (MICs) < 1000 µg/mL) against fungi. The best activity (MICs < 100) have essential oils from some species of the genera Clinopodium, Lavandula, Mentha, Thymbra, and Thymus. In some cases were observed significant discrepancies between different studies. In the review are also shown the most important compounds of described essential oils. To the chemical components most commonly found as the main ingredients include β-caryophyllene (41 plants), linalool (27 plants), limonene (26), β-pinene (25), 1,8-cineole (22), carvacrol (21), α-pinene (21), p-cymene (20), γ-terpinene (20), and thymol (20). Keywords: Labiatae; fungi; Aspergillus; Cryptococcus; Penicillium; dermatophytes; β-caryophyllene; sesquiterpene; monoterpenes; minimal inhibitory concentration (MIC) 1. Introduction Fungal infections belong to the most often diseases of humans.
    [Show full text]
  • Characterization of Keratinophilic Fungal
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 18 September 2018 doi:10.20944/preprints201807.0236.v2 CHARACTERIZATION OF KERATINOPHILIC FUNGAL SPECIES AND OTHER NON-DERMATOPHYTES IN HAIR AND NAIL SAMPLES IN RIYADH, SAUDI ARABIA Suaad S. Alwakeel Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 285876 , Riyadh 11323, Saudi Arabia Telephone: +966505204715 Email: <[email protected]> < [email protected]> ABSTRACT The presence of fungal species on skin and hair is a known finding in many mammalian species and humans are no exception. Superficial fungal infections are sometimes a chronic and recurring condition that affects approximately 10-20% of the world‟s population. However, most species that are isolated from humans tend to occur as co-existing flora. This study was conducted to determine the diversity of fungal species from the hair and nails of 24 workers in the central region of Saudi Arabia. Male workers from Riyadh, Saudi Arabia were recruited for this study and samples were obtained from their nails and hair for mycological analysis using Sabouraud‟s agar and sterile wet soil. A total of 26 species belonging to 19 fungal genera were isolated from the 24 hair samples. Chaetomium globosum was the most commonly isolated fungal species followed by Emericella nidulans, Cochliobolus neergaardii and Penicillium oxalicum. Three fungal species were isolated only from nail samples, namely, Alternaria alternata, Aureobasidium pullulans, and Penicillium chrysogenum. This study demonstrates the presence of numerous fungal species that are not previously described from hair and nails in Saudi Arabia. The ability of these fungi to grow on and degrade keratinaceous materials often facilitates their role to cause skin, hair and nail infections in workers and other persons subjected to fungal spores and hyphae.
    [Show full text]
  • Clinical Policy: Topical Agents: Anti-Fungals Reference Number: OH.PHAR.PPA.90 Effective Date: 01/01/2020 Revision Log Last Review Date: Line of Business: Medicaid
    Clinical Policy: Topical Agents: Anti-Fungals Reference Number: OH.PHAR.PPA.90 Effective Date: 01/01/2020 Revision Log Last Review Date: Line of Business: Medicaid See Important Reminder at the end of this policy for important regulatory and legal information. Description NO PA REQUIRED “PREFERRED” PA REQUIRED “NON-PREFERRED” CICLOPIROX cream, gel, topical suspension, shampoo CICLOPIROX kit (generic of CNL® Nail lacquer kit) (generic of Loprox®) ERTACZO® (sertaconazole) CICLOPIROX solution (generic of Penlac®) EXELDERM® (sulconazole) CLOTRIMAZOLE (generic of Lotrimin®) JUBLIA® solution (efinaconazole) CLOTRIMAZOLE/BETAMETHASONE (generic of KERYDIN® solution (tavaborole) Lotrisone®) KETOCONAZOLE foam(generic of Extina®) ECONAZOLE (generic of Spectazole®) LUZU® (luliconazole) KETOCONAZOLE cream & shampoo (generic of Kuric®, MENTAX® (butenafine) Nizoral®) NAFTIFINE CREAM MICONAZOLE NAFTIN® GEL (naftifine) NYSTATIN OXICONAZOLE (generic of OXISTAT®) NYSTATIN/TRIAMCINOLONE PEDIADERM AF® cream (nystatin) TERBINAFINE (generic of Lamisil®) VUSION® ointment (miconazole/zinc) TOLNAFTATE (generic of Tinactin®) FDA approved indication(s) Ciclopirox is indicated for: • Topical treatment of mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum in immunocompetent patients (Penlac®, Ciclodan Nail Lacquer®) • Topical treatment of seborrheic dermatitis of the scalp (Loprox®) • Topical treatment of tinea corporis, tinea cruris, or tinea pedis (Epidermophyton floccosum; Microsporum canis; Trichophyton
    [Show full text]
  • The New Species Concept in Dermatophytes—A Polyphasic Approach
    Mycopathologia DOI 10.1007/s11046-008-9099-y The New Species Concept in Dermatophytes—a Polyphasic Approach Yvonne Gra¨ser Æ James Scott Æ Richard Summerbell Received: 15 October 2007 / Accepted: 30 January 2008 Ó Springer Science+Business Media B.V. 2008 Abstract The dermatophytes are among the most among these are the cosmopolitan bane of nails and frequently observed organisms in biomedicine, yet feet, Trichophyton rubrum, and the endemic African there has never been stability in the taxonomy, agent of childhood tinea capitis, Trichophyton identification and naming of the approximately 25 soudanense, which are effectively inseparable in all pathogenic species involved. Since the identification analyses. The molecular data require some reinter- of these species is often epidemiologically and pretation of results seen in conventional phenotypic ethically important, the difficulties in dermatophyte tests, but in most cases, phylogenetic insight is identification are a fruitful topic for modern molec- readily integrated with current laboratory testing ular biological investigation, done in tandem with procedures. renewed investigation of phenotypic characters. Molecular phylogenetic analyses such as multilocus Keywords Dermatophytes Á Taxonomy Á sequence typing have had to be tailored to accom- Molecular identification Á modate differing the mechanisms of speciation that Morphological identification Á Species concept have produced the dermatophytes that are commonly seen today. Even so, some biotypes that were unambiguously considered species in the past, based Introduction: Why Dermatophyte Biosystematics on profound differences in morphology and pattern of and Identification are Important (Medical infection, appear consistently not to be distinct and Scientific Aspects) species in modern molecular analyses. Most notable The dermatophytes belong to the small category of disease organisms that almost every human alive will Y.
    [Show full text]
  • How Much Human Ringworm Is Zoophilic? Mcphee A, Cherian S, Robson J Adapted from Poster Produced for the Zoonoses Conference 25–26 July 2014 Brisbane
    How much human ringworm is zoophilic? McPhee A, Cherian S, Robson J Adapted from poster produced for the Zoonoses Conference 25–26 July 2014 Brisbane Introduction Epidermophyton floccosum Humans Common Dermatophytes can be the cause of common infections in both Trichophyton rubrum [worldwide] Humans Very common humans and animals. The source of human infection may be Trichophyton rubrum [African] Humans Less common anthropophilic (human), geophilic (soil) or zoophilic (animal). Trichophyton interdigitale Anthropophilic Humans Common Zoophilic dermatophyte infections usually elicit a strong host [anthropophilic] response on the skin where there is contact with the infective Trichophyton tonsurans Humans Common animal or contaminated fomites. Table 1 illustrates the range of Trichophyton violaceum Humans Less common dermatophytes that are isolated from the mycology laboratory Microsporum audouinii Humans Less common and grouped by source of acquisition. Microsporum gypseum Soil Common Geophilic Microsporum nanum Soil/Pigs Rare Guinea pigs, Aim Trichophyton interdigitale [zoophilic] Common kangaroos To characterize and compare zoophilic with non-zoophilic Microsporum canis Cats Common dermatophyte human infections isolated at Sullivan Nicolaides Zoophilic Trichophyton verrucosum Cattle Rare Pathology (SNP) for the year 2013. Trichophyton equinum Horses Rare Microsporum nanum Soil/pigs Rare Method Table 1: Classification of dermatophytes according to source Superficial fungal cultures submitted in 2013 to Sullivan Nicolaides Pathology were reviewed. This laboratory services Queensland and extends into New South Wales as far south as Coffs Harbour. Specimens include skin scrapings, skin biopsies, nails and involved hair. All cutaneous samples (Figure 1) submitted for fungal culture receive direct examination using Calcofluor white/Evans Blue/ KOH/Glycerol under fluorescent and/or light microscopy (Figure 2) and cultured.
    [Show full text]
  • Oxistat (Oxiconazole)
    Federal Employee Program® 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.13 Section: Prescription Drugs Effective Date: October 1, 2020 Subsection: Topical Products Original Policy Date: June 5, 2015 Subject: Oxistat Page: 1 of 4 Last Review Date: September 11, 2020 Oxistat Description Oxistat (oxiconazole) Background Oxistat is used to treat skin infections such as athlete's foot (tinea pedis), jock itch (tinea cruris) and ringworm (tinea corporis). This medication is also used to treat a skin condition known as tinea (pityriasis) versicolor, a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Oxiconazole is an azole antifungal that works by preventing the growth of fungus (1). Regulatory Status FDA-approved indications: Oxistat is an azole antifungal indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. Oxistat is also indicated for the topical treatment of tinea (pityriasis) versicolor due to Malassezia furfur (1). Safety and effectiveness of Oxistat in pediatric patients have been established (1). Related policies Ecoza, Ertaczo, Exelderm, Jublia, Kerydin, Luzu 5.90.13 Section: Prescription Drugs Effective Date: October 1, 2020 Subsection: Topical Products Original Policy Date: June 5, 2015 Subject: Oxistat Page: 2 of 4 Policy This policy statement applies to clinical review performed for pre-service (Prior Approval, Precertification, Advanced Benefit Determination, etc.) and/or post-service claims. Oxistat may be considered medically necessary in patients with interdigital tinea pedis, tinea cruris, tinea corporis and tinea versicolor with laboratory and clinical documentation of one of the infections: Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum and Malassezia furfur and if the conditions indicated below are met.
    [Show full text]
  • Serious Fungal Infections in Portugal
    Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-017-2930-y ORIGINAL ARTICLE Serious fungal infections in Portugal R. Sabino1 & C. Verissímo 1 & J. Brandão1 & C. Martins2 & D. Alves2 & C. Pais3 & D. W. Denning4 Received: 21 December 2016 /Accepted: 21 December 2016 # Springer-Verlag Berlin Heidelberg 2017 Abstract There is a lack of knowledge on the epidemiology aspergillosis after tuberculosis (TB) is 194 cases, whereas its of fungal infections worldwide because there are no reporting prevalence for all underlying pulmonary conditions was 776 obligations. The aim of this study was to estimate the burden patients. Asthma is common (10% in adults) and we estimate of fungal disease in Portugal as part of a global fungal burden 16,614 and 12,600 people with severe asthma with fungal project. Most published epidemiology papers reporting fungal sensitisation and allergic bronchopulmonary aspergillosis, re- infection rates from Portugal were identified. Where no data spectively. Sixty-five patients develop Pneumocystis pneumo- existed, specific populations at risk and fungal infection fre- nia in acquired immune deficiency syndrome (AIDS) and 13 quencies in those populations were used in order to estimate develop cryptococcosis. Overall, we estimate a total number national incidence or prevalence, depending on the condition. of 1,695,514 fungal infections starting each year in Portugal. An estimated 1,510,391 persons develop a skin or nail fungal infection each year. The second most common fungal infec- tion in Portugal is recurrent vulvovaginal candidiasis, with an Introduction estimated 150,700 women (15–50 years of age) suffering from it every year. In human immunodeficiency virus Despite their growing importance, many fungal infections (HIV)-infected people, oral or oesophageal candidiasis rates have been neglected all over the world until recently.
    [Show full text]
  • REVIZIJA RIZOMATOZNIH VRST LUKA (Allium) V SLOVENIJI
    UNIVERZA V LJUBLJANI BIOTEHNIŠKA FAKULTETA ODDELEK ZA BIOLOGIJO Petra SLADEK REVIZIJA RIZOMATOZNIH VRST LUKA (Allium) V SLOVENIJI DIPLOMSKO DELO Univerzitetni študij Ljubljana, 2016 UNIVERZA V LJUBLJANI BIOTEHNIŠKA FAKULTETA ODDELEK ZA BIOLOGIJO Petra SLADEK REVIZIJA RIZOMATOZNIH VRST LUKA (Allium) V SLOVENIJI DIPLOMSKO DELO Univerzitetni študij REVISION OF RHIZOMATOUS ALLIUM SPECIES (Allium) IN SLOVENIA B. SC. THESIS Academic Study Programmes Ljubljana, 2016 ''... whilst this planet has gone cycling on according to the fixed law of gravity, from so simple a beginning endless forms most beautiful and most wonderful have been, and are being evolved.'' (Charles Darwin: The Origin of Species, 1872) Sladek P. Revizija rizomatoznih vrst luka (Allium) v Sloveniji. Dipl. delo. Ljubljana, Univ. v Ljubljani, Biotehniška fakulteta, Odd. za biologijo, 2016 Diplomsko delo je zaključek univerzitetnega študija Biologije. Delo sem opravljala na Katedri za botaniko, Oddelka za biologijo Biotehniške fakultete, Univerze v Ljubljani. Študijska komisija Oddelka za biologijo je dne 20. 5. 2005 za mentorja diplomske naloge imenovala prof. dr. Jerneja Jogana, 20. 5. 2016 za predsednico doc. dr. Simono Strgulc-Krajšek in za recenzentko doc. dr. Martino Bačič. Komisija za oceno in zagovor: Predsednica: doc. dr. Simona STRGULC-KRAJŠEK Univerza v Ljubljani, Biotehniška fakulteta, Oddelek za biologijo Mentor: prof. dr. Jernej JOGAN Univerza v Ljubljani, Biotehniška fakulteta, Oddelek za biologijo Recenzentka: doc. dr. Martina BAČIČ Univerza v Ljubljani, Biotehniška fakulteta, Oddelek za biologijo Datum zagovora: 15. 7. 2016 Podpisana izjavljam, da je diplomsko delo rezultat lastnega raziskovalnega dela. Izjavljam, da je elektronski izvod identičen tiskanemu. Na univerzo neodplačno, neizključno, prostorsko in časovno neomejeno prenašam pravici shranitve avtorskega dela v elektronski obliki in reproduciranja ter pravico omogočanja javnega dostopa do avtorskega dela na svetovnem spletu preko Digitalne knjižnice Biotehniške fakultete.
    [Show full text]